$-0.37 EPS Expected for EXACT Sciences (EXAS), Freestone Capital Holdings Cut Its Anheuser Busch Inbev Sa/Nv (BUD) Stake

July 24, 2017 - By test

Freestone Capital Holdings Llc decreased Anheuser Busch Inbev Sa/Nv (BUD) stake by 21.5% reported in 2016Q4 SEC filing. Freestone Capital Holdings Llc sold 10,264 shares as Anheuser Busch Inbev Sa/Nv (BUD)’s stock rose 8.45%. The Freestone Capital Holdings Llc holds 37,479 shares with $3.95M value, down from 47,743 last quarter. Anheuser Busch Inbev Sa/Nv now has $192.66B valuation. The stock decreased 0.67% or $0.77 during the last trading session, reaching $114.74. About 3,400 shares traded. Anheuser Busch Inbev NV (ADR) (NYSE:BUD) has declined 3.55% since July 24, 2016 and is downtrending. It has underperformed by 20.25% the S&P500.

Analysts expect EXACT Sciences Corporation (NASDAQ:EXAS) to report $-0.37 EPS on July, 25 before the open.They anticipate $0.09 EPS change or 19.57% from last quarter’s $-0.46 EPS. After having $-0.32 EPS previously, EXACT Sciences Corporation’s analysts see 15.63% EPS growth. The stock increased 0.33% or $0.13 on July 21, reaching $39.17. About shares traded. EXACT Sciences Corporation (NASDAQ:EXAS) has risen 458.24% since July 24, 2016 and is uptrending. It has outperformed by 441.54% the S&P500.

Freestone Capital Holdings Llc increased Intel Corp (NASDAQ:INTC) stake by 14,443 shares to 112,603 valued at $4.08 million in 2016Q4. It also upped Ishares Tr (IWM) stake by 2,842 shares and now owns 77,751 shares. Boeing Co (NYSE:BA) was raised too.

Among 21 analysts covering Anheuser-Busch InBev (NYSE:BUD), 13 have Buy rating, 1 Sell and 7 Hold. Therefore 62% are positive. Anheuser-Busch InBev has $157 highest and $100 lowest target. $121.59’s average target is 5.97% above currents $114.74 stock price. Anheuser-Busch InBev had 35 analyst reports since July 21, 2015 according to SRatingsIntel. The rating was reinitiated by JP Morgan on Tuesday, October 11 with “Neutral”. As per Friday, February 26, the company rating was maintained by Stifel Nicolaus. The stock has “Outperform” rating by Credit Agricole on Monday, November 2. As per Tuesday, September 13, the company rating was initiated by Jefferies. The rating was maintained by Susquehanna on Friday, May 5 with “Hold”. The stock of Anheuser Busch Inbev NV (ADR) (NYSE:BUD) has “Buy” rating given on Monday, October 3 by Liberum Capital. The firm earned “Overweight” rating on Wednesday, October 5 by Morgan Stanley. The stock of Anheuser Busch Inbev NV (ADR) (NYSE:BUD) has “Buy” rating given on Tuesday, April 5 by Societe Generale. The firm has “Neutral” rating given on Tuesday, July 21 by Nomura. Vetr upgraded Anheuser Busch Inbev NV (ADR) (NYSE:BUD) rating on Thursday, August 13. Vetr has “Buy” rating and $134.75 target.

Investors sentiment decreased to 1 in Q4 2016. Its down 0.02, from 1.02 in 2016Q3. It dived, as 66 investors sold BUD shares while 144 reduced holdings. 61 funds opened positions while 150 raised stakes. 78.58 million shares or 13.08% less from 90.41 million shares in 2016Q3 were reported. Greenleaf owns 27,268 shares. Moreover, Ativo Cap Mngmt Lc has 0.46% invested in Anheuser Busch Inbev NV (ADR) (NYSE:BUD) for 18,681 shares. Southeast Asset Advsrs Incorporated holds 0.14% or 4,322 shares. Cramer Rosenthal Mcglynn Ltd Liability Com holds 0.18% of its portfolio in Anheuser Busch Inbev NV (ADR) (NYSE:BUD) for 117,122 shares. Royal National Bank Of Canada stated it has 566,688 shares. Oz Mngmt LP holds 140,510 shares or 0.1% of its portfolio. Comerica National Bank has invested 0.08% of its portfolio in Anheuser Busch Inbev NV (ADR) (NYSE:BUD). The New York-based Jpmorgan Chase has invested 0.01% in Anheuser Busch Inbev NV (ADR) (NYSE:BUD). Verition Fund stated it has 0.04% in Anheuser Busch Inbev NV (ADR) (NYSE:BUD). 408 are held by Central Savings Bank Tru. Northern Corporation holds 1.10 million shares or 0.04% of its portfolio. Reliance Of Delaware reported 16,304 shares stake. Pecaut has 3,900 shares. Montecito Bancorporation Tru holds 0.03% of its portfolio in Anheuser Busch Inbev NV (ADR) (NYSE:BUD) for 683 shares. Eagle Global Advsr Ltd Company stated it has 0.11% in Anheuser Busch Inbev NV (ADR) (NYSE:BUD).

Analysts await Anheuser Busch Inbev NV (ADR) (NYSE:BUD) to report earnings on July, 27 before the open. They expect $1.14 EPS, up 7.55% or $0.08 from last year’s $1.06 per share. BUD’s profit will be $1.91 billion for 25.16 P/E if the $1.14 EPS becomes a reality. After $0.74 actual EPS reported by Anheuser Busch Inbev NV (ADR) for the previous quarter, Wall Street now forecasts 54.05% EPS growth.

Investors sentiment decreased to 1.08 in 2016 Q4. Its down 0.40, from 1.48 in 2016Q3. It dived, as 35 investors sold EXACT Sciences Corporation shares while 56 reduced holdings. 31 funds opened positions while 67 raised stakes. 88.31 million shares or 1.12% more from 87.34 million shares in 2016Q3 were reported. Sg Americas Securities Ltd Liability reported 0% stake. Artemis Invest Mgmt Llp has invested 0.06% in EXACT Sciences Corporation (NASDAQ:EXAS). Quantbot Technologies L P owns 544 shares for 0% of their portfolio. Kornitzer Cap Mgmt Inc Ks owns 791,965 shares for 0.2% of their portfolio. Carl Domino reported 25,000 shares stake. Millrace Asset Gru reported 64,939 shares. Massachusetts Financial Serv Co Ma invested in 423,686 shares or 0% of the stock. Invesco holds 0% or 853,298 shares. 312,820 were reported by Susquehanna Limited Liability Partnership. Shannon River Fund Mngmt Limited Liability Com, a New York-based fund reported 550,000 shares. The Connecticut-based Point72 Asset Mngmt L P has invested 0.01% in EXACT Sciences Corporation (NASDAQ:EXAS). Finance Advisory reported 10,000 shares. Oxbow Ltd Liability Corporation holds 0.02% in EXACT Sciences Corporation (NASDAQ:EXAS) or 10,000 shares. Schwab Charles Inv Mgmt owns 418,230 shares. Ny State Common Retirement Fund, New York-based fund reported 126,100 shares.

Exact Sciences Corporation is a molecular diagnostics company. The company has market cap of $4.65 billion. The Firm focuses on the early detection and prevention of some forms of cancer. It currently has negative earnings. It offers a non-invasive screening test called Cologuard for the early detection of colorectal cancer and pre-cancer.

Since February 24, 2017, it had 0 insider buys, and 9 sales for $1.67 million activity. The insider Conroy Kevin T sold $583,520. 8,668 shares were sold by LIDGARD GRAHAM PETER, worth $186,429. Shares for $41,960 were sold by COWARD D SCOTT on Monday, March 13. ARORA MANEESH also sold $238,968 worth of EXACT Sciences Corporation (NASDAQ:EXAS) shares.

Among 14 analysts covering EXACT Sciences (NASDAQ:EXAS), 8 have Buy rating, 1 Sell and 5 Hold. Therefore 57% are positive. EXACT Sciences had 41 analyst reports since July 24, 2015 according to SRatingsIntel. The stock of EXACT Sciences Corporation (NASDAQ:EXAS) has “Buy” rating given on Thursday, February 25 by Jefferies. The rating was maintained by Canaccord Genuity on Wednesday, October 7 with “Buy”. Roth Capital downgraded the stock to “Neutral” rating in Thursday, February 25 report. Canaccord Genuity maintained EXACT Sciences Corporation (NASDAQ:EXAS) on Monday, August 24 with “Buy” rating. Benchmark maintained the shares of EXAS in report on Wednesday, October 26 with “Hold” rating. Benchmark upgraded the shares of EXAS in report on Tuesday, February 21 to “Buy” rating. The stock of EXACT Sciences Corporation (NASDAQ:EXAS) earned “Neutral” rating by Wedbush on Thursday, October 8. The stock of EXACT Sciences Corporation (NASDAQ:EXAS) earned “Equal-Weight” rating by Stephens on Thursday, February 25. The company was maintained on Tuesday, October 6 by Goldman Sachs. The stock of EXACT Sciences Corporation (NASDAQ:EXAS) earned “Buy” rating by TH Capital on Tuesday, October 6.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Twitter Auto Publish Powered By : XYZScripts.com